Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 10 , ISSUE 1 ( January-March, 2016 ) > List of Articles

REVIEW ARTICLE

Fetal Ultrasound as a Window into Maternal Health

Kelly Yamasato, Janet Burlingame

Keywords : Autoimmune diseases,Congenital heart block,Diabetes mellitus,Fetal alcohol syndrome,Fetal macrosomia,Intrauterine growth retardation,Maternal exposure,Teratogen,Ultrasound prenatal

Citation Information : Yamasato K, Burlingame J. Fetal Ultrasound as a Window into Maternal Health. Donald School J Ultrasound Obstet Gynecol 2016; 10 (1):37-41.

DOI: 10.5005/jp-journals-10009-1440

License: CC BY-NC 4.0

Published Online: 01-09-2016

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

How to cite this article

Yamasato K, Burlingame J. Fetal Ultrasound as a Window into Maternal Health. Donald School J Ultrasound Obstet Gynecol 2016;10(1):37-41.


PDF Share
  1. Birthweight of offspring and mortality of parents: The Jerusalem perinatal study cohort. Ann Epidemiol 2007;17(11):914-922.
  2. Fetal growth restriction. Practice Bulletin No. 134. Obstet Gynecol 2013;121(5):1122-1133.
  3. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO study. Am J Obstet Gynecol 2013;208(4):290.e1-6.
  4. Fetal Macrosomia. Obstet Gynecol 2000;96(5).
  5. Fetal macrosomia: etiologic factors. Clin Obset Gynecol 2000;43(2):283-297.
  6. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 2011;124:2839-2846.
  7. The effect of gestational weight gain by body mass index on maternal and neonatal outcomes. J Obstet Gynaecol Can 2009;31(1):28-35.
  8. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol and Repro Biol 2003;111(1):9-14.
  9. Other adverse pregnancy outcomes and future chronic disease. Semin Perinatol 2015;39(4):259-263.
  10. Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease. PLoS ONE 2012;7(3):e33047.
  11. Aberrant maternal inflammation as a cause of pregnancy complications: a potential therapeutic target? Placenta 2015;36(8):960-966.
  12. Update on overall prevalence of major birth defects—Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57(1):1-5.
  13. Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World J Diabetes 2015;6(3):481-488.
  14. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31(5):899-904.
  15. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001;61(2):85-95.
  16. Threshold values of maternal blood glucose in early diabetic pregnancy—prediction of fetal malformations. Acta Obstet Gynecol Scand 2005;84(1):17-25.
  17. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182(2):313-320.
  18. Major congenital malformations in women with gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Res Rev 2012;28(3):252-257.
  19. Relationship between haemoglobin A1c in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990;33(2):100-104.
  20. Clinical relevance of sonographically estimated amniotic fluid volume: Polyhydramnios. J Ultrasound Med 2013;32(5):851-863.
  21. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed 2004;75(Suppl 1):53-55.
  22. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011;40(1):27-41.
  23. Medication use in pregnancy: a cross-sectional, multinational web-based survey. BMJ Open 2014;4(2):e004365.
  24. Alcohol use and binge drinking among women of childbearing age— United States, 2006-2010. Morb Mortal Wkly Rep 2012;61(28): 534-538.
  25. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res 2012;36(4):670-676.
  26. Biochemical markers of alcohol use in pregnant women. Clin Biochem 2003;36(1):9-19.
  27. Can prenatal ultrasound detect the effects of in-utero alcohol exposure? A pilot study. Ultrasound Obstet Gynecol 2009;33(6):683-689.
  28. Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol 2015;125(6): 1510-1525.
  29. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31(7):1658-1666.
  30. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and anti-La/SSB antibodies. Ultrasound Q 2015;31(1):34-36.
  31. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther 2005;7(2):69-73.
  32. Anti-SSA antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheumatism 1986;29(10):1269-1273.
  33. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44(8):1832-1835.
  34. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001;44(2):487-488.
  35. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus. Rheumatology 2012;51(6):1086-1092.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.